Abstract
Background
Recent studies have shown that intraoperative blood loss and blood transfusions promote postoperative recurrence of hepatocellular carcinoma (HCC). Hyperbaric oxygen therapy (HBOT) is a specific method of oxygen administration, which is independent of fluid therapy or blood transfusion. The aim of the present study was to assess the usefulness of acute HBOT after liver resection for patients with HCC in order to minimize the requirement for perioperative blood transfusions.
Patients and methods
Forty-one consecutive patients who showed Hb level < 9.0 mg/dl at the end of hepatic resection were randomly assigned to a control group (n = 21) or an HBOT group (n = 20). HBOT at 2.0 atm. with inhalation of 100% oxygen for a duration of 60 min was performed at 3, 24, and/or 48 h after the end of the hepatectomy. Regarding postoperative hepatic hemodynamics, liver function tests, and outcome data, prospective comparisons were completed in both groups. The two groups of patients were similar with respect to results from preoperative assessments.
Results
In six patients from the HBOT group, who experienced intraoperative major bleeding or showed fatal hepatic hypoxia (ShvO2 < 50%), the levels of ShvO2 and serum lactate were significantly improved after HBOT. When compared to the control group, the HBOT group showed better changes of ShvO2, serum lactate, and bilirubin levels for the first 3 postoperative days following surgery. Additionally, the HBOT group did not experience any fatal complications and had a lower incidence of postoperative hyperbilirubinemia than the control group. We also observed that postoperative NK cell activity and cancer-free survival in the HBOT group tended to be better than in the control group, although the differences did not reach significance.
Conclusion
These results suggest that acute HBOT after hepatectomy, aimed at reducing perioperative erythrocyte transfusions, may be employed for overcoming deficiencies in systemic and hepatic oxygen supply and thus diminishing postoperative complications. As an added benefit, such therapy may affect postoperative immunological responses and long-term survival after liver resection in HCC patients. Further analyses of the use of HBOT is warranted to confirm surgical outcome data and to assess the economic impact on healthcare costs.
Similar content being viewed by others
References
Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H et al (1994) Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 115:303–309
Johnson LB, Plotkin JS, Kuo PC (1998) Reduced transfusion requirements during major hepatic resection with use of intraoperative isovolemic hemodilution. Am J Surg 176:608–611
Asahara T, Katayama K, Itamoto T, Yano M, Hino H, Okamoto Y et al (1999) Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg 23:676–680
Ueno S, Tanabe G, Yoshida A, Yoshidome S, Takao S, Aikou T (1999) Postoperativeprediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis. Cancer 86:248–254
Makino Y, Yamanoi A, Kimoto T, El-Assal ON, Kohno H, Nagasue N (2000) The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. Am J Gastroenterol 95:1294–1300
Poon RT, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232:10–24
Wu CC, Cheng SB, Ho WM, Chen JT, Liu TJ, FK PuCC (2005) Liver resection for Hepatocellular Carcinoma in patients with cirrhosis. Br J Surg 92:348–355
de Boer MT, Molenaar IQ, Porte RJ (2007) Impact of blood loss on outcome after liver resection. Dig Surg 24:259–264
Wang CC, Lyer SG, Low JK, Lin CY, Wang SH, Lu SN et al (2009) Preoperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 16:1832–1842
Taketomi A, Toshima T, Kitagawa D, Motomura T, Takeishi K, Mano Y et al (2010) Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol: Epub ahead of print
Makuuchi M, Takayama T, Gunven P, Kosuge T, Yamazaki S, Hasegawa H (1989) Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World J Surg 13:644–648
Itamoto T, Katayama K, Nakahara H, Tashiro H, Asahara T (2003) Autologous blood storage before hepatectomy for hepatocellular carcinoma with underlying liver disease. Br J Surg 90:23–28
Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM et al (2001) Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234:63–70
Nonami T, Asahi K, Harada A, Nakao A, Takagi H (1991) Effect of hyperdynamic circulatory support on hepatic hemodynamics, oxygen supply and demand after massive hepatectomy. Surgery 109:277–283
Ueno S, Tanabe G, Yamada H, Kusano C, Yoshidome S, Nuruki K et al (1998) Response of patients with cirrhosis who have undergone partial hepatectomy to treatment aimed at achieving supranormal oxygen delivery and consumption. Surgery 123:278–286
Kawamura M, Sakakibara K, Yusa T (1978) Effect of increased oxygen on peripheral circulation in acute, temporary limb hypoxia. J Cardiovasc Surg 19:161–168
Chuba PJ, Aronin P, Bhambhani K, Eichenhorn M, Zamarano L, Cianci P et al (1997) Hyperbaric oxygen therapy for radiation-induced brain injury in children. Cancer 15:2005–2012
Roeckl-Wiedmann I, BennettM KP (2005) Systematic review of hyperbaric oxygen in the management of chronic wounds. Br J Surg 92:24–32
Weiland DE (2007) Fasciotomy closure using simultaneous vacuum-assisted closure and hyperbaric oxygen. Am Surg 73:261–266
Ueno S, Tanabe G, Kihara K, Aoki D, Arikawa K, Dogomori H et al (1999) Early postoperative hyperbaric oxygen therapy modifies neutrophil activation. Hepatogastroenterology 46:1798–1799
Kihara K, Ueno S, Sakoda M, Aikou T (2005) Effects of hyperbaric oxygen exposure on experimental hepatic ischemia reperfusion injury: relationship between its timing and neutrophil sequestration. Liver Transpl 11:1574–1580
Sakoda M, Ueno S, Kihara K, Aikou T (2004) A potential role of hyperbaric oxygen exposure through intestinal nuclear factor-kappa B. Crit Care Med 32:1722–1729
Kainuma M, Nakashima K, Sakuma I (1992) Hepatic venous hemoglobin oxygen saturation predicts liver dysfunction after hepatectomy. Anesthesiology 76:379–386
Brittenden J, Heys SD, Ross J, Eremin O (1996) Natural killer cells and cancer. Cancer 77:1226–1243
Yoshioka S, Miyazaki M, Shimizu H, Ito H, Nakagawa K, Ambiru S et al (1998) Hepatic venous hemoglobin oxygen saturation predicts regenerative status of remnant liver after partial hepatectomy in rats. Hepatology 27:1349–1353
Vlahakes GJ (2001) Haemoglobin solutions in surgery. Br J Surg 88:1553–1555
Tanabe G, Kawaida K, Hamanoue M, Kihara K, Hirata S, Maemura M et al (1999) Treatment for accidental occlusion of the hepatic artery after hepatic resection: report of two cases. Surg Today 29:268–272
Schwesinger WH, Kurtin WE (1983) Changes in serum and bile bilirubin induced by acute hemolysis. J Surg Res 35:520–530
Torzilli G, Gambetti A, Del Fabbro D, Leoni P, Olivari N, Donadon M et al (2004) Techniques for hepatectomies without blood transfusion, focusing on interpretation of postoperative anemia. Arch Surg 139:1061–1065
Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C et al (1999) Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229:322–330
Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F et al (1999) Continuous versus intermittent portal triad clamping for liver resection. Ann Surg 229:369–375
Lasek W, Plodziszewska M, Jakobisiak M (1987) The effect of blood donation on natural killer activity in man. J Clin Lab Immunol 22:165–168
Tartter PI, Burrows L, Papatestas AE, Lesnick G, Aufses AH Jr (1985) Perioperative blood transfusion has prognostic significance for breast cancer. Surgery 97:225–230
Van Lawick van Pabst WP, Langenhorst BL, Mulder PG, Marquet RL, Jeekel J (1988) Effect of perioperative blood loss and perioperative blood transfusion on colorectal cancer survival. Eur J Cancer Clin Oncol 24:741–747
Tartter PI, Martinelli G (1987) Lymphocyte subsets, natural killer cytotoxicity, and perioperative blood transfusion for elective colorectal cancer surgery. Cancer Detect Prev Suppl 1:571–576
Matsumata T, Ikeda Y, Hayashi H, Kamakura T, Taketomi A, Sugimachi K (1993) The association between transfusion and cancer-free survival after curative resection for hepatocellular carcinonoma. Cancer 72:1866–1871
Kwon AH, Matsui Y, Kamiyama Y (2001) Perioperative blood transfusion in hepatocellular carcinoma. Cancer 91:771–778
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ueno, S., Sakoda, M., Kurahara, H. et al. Safety and efficacy of early postoperative hyperbaric oxygen therapy with restriction of transfusions in patients with HCC who have undergone partial hepatectomy. Langenbecks Arch Surg 396, 99–106 (2011). https://doi.org/10.1007/s00423-010-0725-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-010-0725-z